Kady Conrad
Family · Hickory, NCNPI 1306578919
Payments from drug & device makers
Across 73 payments — averaging $17.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$332
- AbbVie$253
- TG Therapeutics, Inc.$85
- UCB, Inc.$71
- Lilly USA, LLC$57
- Argenx US, Inc.$55
- plus $405 from 16 others
What the payments were for
- Food & beverage$1,17894%
- Education$806%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 16 | $332 |
| AbbVie | 26 | $253 |
| TG Therapeutics, Inc. | 3 | $85 |
| UCB, Inc. | 2 | $71 |
| Lilly USA, LLC | 3 | $57 |
| Argenx US, Inc. | 3 | $55 |
| MDD US Operations, LLC | 3 | $53 |
| Amneal Pharmaceuticals LLC | 2 | $38 |
| Impel Pharmaceuticals LLC | 2 | $34 |
| Medtronic | 1 | $31 |
| Sanofi | 1 | $29 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| Johnson & Johnson | 1 | $26 |
| Averitas Pharma Inc. | 1 | $25 |
| EMD Serono, Inc. | 1 | $22 |
| RARE Disease Therapeutics, Inc. | 1 | $20 |
| Amgen | 1 | $19 |
| Pfizer | 1 | $18 |
| Aucta Pharmaceuticals, Inc. | 1 | $17 |
| Lundbeck LLC | 1 | $17 |
| AstraZeneca | 1 | $15 |
| Biogen | 1 | $15 |
How this compares
$1,257 in reported general payments places this provider in the 70th percentile of 4,522 family providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone Propionate | 21 | $175 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 27 | $162 |
| Doxycycline Hyclate | 13 | $128 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 12 | $110 |
Paid to pharmacies, not to this prescriber.
Other family in Hickory
- Kelly HolmesHickory$55K
- Tanya DyerHickory$21K
- Leslie ByrneFayetteville$482K
- Michele CerraRaleigh$332K
- Anne LakeArchdale$306K
- Carrie PettitRaleigh$298K
- Nicole RothmanDurham$268K
- Meredith LeaYanceyville$253K
- Jennifer GibbsRaleigh$216K
- Juanita PerkinsDurham$213K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.